Hypertension: comparison of drug and non-drug treatments.

Treatment of high blood pressure: should clinical practice be based on results of clinical trials? Br Med J (Clin Res Ed) (1986) 1.31

Beta blockade, diuretics, and salt restriction for the management of mild hypertension: a randomised double blind trial. Br Med J (Clin Res Ed) (1984) 1.16

Relaxation therapy and continuous ambulatory blood pressure in mild hypertension: a controlled study. BMJ (1990) 1.06

Effect of pranayama on rate pressure product in mild hypertensives. Int J Appl Basic Med Res (2014) 0.76

The management of hypertension. Br J Clin Pharmacol (1986) 0.75

Antihypertensive effect of diet compared with drug treatment in obese men with mild hypertension. BMJ (1989) 0.75

On the promotion of non-drug treatments. Br Med J (Clin Res Ed) (1984) 0.75

Hypertension. Current therapeutic practice reviewed. Drugs (1986) 0.75

Hypertension treated by salt restriction. Lancet (1978) 3.59

Moderate sodium restriction and diuretics in the treatment of hypertension. Am Heart J (1973) 3.12

The Australian therapeutic trial in mild hypertension. Report by the Management Committee. Lancet (1980) 2.81

Treatment of mild hypertension: results of a ten-year intervention trial. Circ Res (1977) 2.20

The effect of weight reduction on blood pressure, plasma renin activity, and plasma aldosterone levels in obese patients. N Engl J Med (1981) 2.05

Blood pressure reduction in "borderline" hypertensives following physical training. Can Med Assoc J (1973) 2.03

Decreased blood-pressure in pharmacologically treated hypertensive patients who regularly elicited the relaxation response. Lancet (1974) 1.94

Randomised controlled trial of yoga and bio-feedback in management of hypertension. Lancet (1975) 1.89

Yoga and bio-feedback in the management of hypertension. Lancet (1973) 1.68

Exercise therapy in hypertensive men. JAMA (1970) 1.58

Decreased systolic blood pressure through operant conditioning techniques in patients with essential hypertension. Science (1971) 1.54

Learned control of blood pressure in patients with high blood pressure. Circulation (1975) 1.32

"Shavasan": A yogic exercise in the management of hypertension. Angiology (1969) 1.29

Relaxation therapy and high blood pressure. Arch Gen Psychiatry (1977) 1.27

Long-term effect of relaxation on blood pressure and anxiety levels of essential hypertensive males: a controlled study. Psychosom Med (1979) 1.26

Transcendental meditation in hypertension. Individual response patterns. Lancet (1976) 1.24

Instrumental conditioning of diastolic blood pressure in essential hypertensive patients. J Appl Behav Anal (1973) 1.10

Decreased blood pressure in borderline hypertensive subjects who practiced meditation. J Chronic Dis (1974) 1.02

Instrumental blood pressure conditioning in out-patient hypertensives. Behav Res Ther (1975) 1.01

Hypertension treated by sodium restriction. Med J Aust (1981) 1.00

Reduction of serum cholesterol and blood pressure in hypertensive patients by behaviour modification. J R Coll Gen Pract (1976) 0.96

Relationship between essential hypertension and cognitive functioning: effects of biofeedback. Psychophysiology (1975) 0.95

Muscle biofeedback and transcendental meditation. A controlled evaluation of efficacy in the treatment of chronic anxiety. Arch Gen Psychiatry (1980) 0.94

Blood pressure reductions during self-recording of home blood pressure. Am Heart J (1979) 0.91

Hemodynamic and metabolic effects of physical training in four patients with essential hypertension. Can Med Assoc J (1967) 0.91

Antihypertensive effects of behavioral treatments and medications compared. N Engl J Med (1980) 0.90

Limitations of transcendental meditation in the treatment of essential hypertension. Lancet (1977) 0.86

Relaxation training, twenty-four-hour blood pressure reductions. Arch Gen Psychiatry (1980) 0.85

Treatment of hypertension with biofeedback and relaxation techniques. Psychosom Med (1978) 0.85

Reassurance in the management of benign hypertensive disease. Circulation (1956) 0.81

A script for deep muscle relaxation. Dis Nerv Syst (1977) 0.81

Relationship between essential hypertension and cognitive functioning. II. Effects of biofeedback training generalize to non-laboratory environment. Psychophysiology (1977) 0.78

Yoga and biofeedback in the management of hypertension. J Psychosom Res (1975) 0.78

Effects of individual and group relaxation therapy on blood pressure in essential hypertensives. Res Nurs Health (1979) 0.78

A survey of patterns of nonpharmacologic care for hypertensive patients, including recommendations for their children. Hypertension (1980) 0.77

Short screening scales to monitor population prevalences and trends in non-specific psychological distress. Psychol Med (2002) 24.22

The performance of the K6 and K10 screening scales for psychological distress in the Australian National Survey of Mental Health and Well-Being. Psychol Med (2003) 6.11

Do doctors know best? Comments on a failed trial. Med J Aust (2001) 4.27

Three year evaluation of a programme by general practitioners to help patients to stop smoking. Br Med J (Clin Res Ed) (1986) 2.86

The effects of drug treatment for hypertension on morbidity and mortality from cardiovascular disease: a review of randomized controlled trials. Prog Cardiovasc Dis (1987) 2.77

The effect of exercise on depression, anxiety and other mood states: a review. J Psychosom Res (1993) 2.46

Placebo response in depression: bane of research, boon to therapy. Br J Psychiatry (2001) 2.46

Measuring social relationships. The Interview Schedule for Social Interaction. Psychol Med (1980) 2.13

An analysis of a token economy in stuttering therapy. J Appl Behav Anal (1973) 2.03

Talk that works: the rise of cognitive behaviour therapy. BMJ (1996) 1.98

Evidence of a genetic contribution to functional bowel disorder. Am J Gastroenterol (1998) 1.96

A scale to measure the stress of life events. Aust N Z J Psychiatry (1976) 1.95

The effect of weight reduction on left ventricular mass. A randomized controlled trial in young, overweight hypertensive patients. N Engl J Med (1986) 1.70

Continuities between psychiatric disorders in adolescents and personality disorders in young adults. Am J Psychiatry (1995) 1.61

Does psychotherapy benefit neurotic patients. Arch Gen Psychiatry (1981) 1.60

The long-term outcome of depressive illness. Br J Psychiatry (1988) 1.60

Australia's mental health: an overview of the general population survey. Aust N Z J Psychiatry (2000) 1.59

Emotional disorders: cluster 4 of the proposed meta-structure for DSM-V and ICD-11. Psychol Med (2009) 1.56

Diabetes and the risk of stroke. The Honolulu Heart Program. JAMA (1987) 1.50

Brief psychotherapy in family practice. A controlled prospective intervention trial. Br J Psychiatry (1983) 1.49

Rheumatoid arthritis with secondary amyloidosis and malabsorption syndrome. Effect of D-penicillamine. Am J Med (1968) 1.39

The changing nature of psychiatry. Aust N Z J Psychiatry (1992) 1.38

Oral health status and treatment needs of non-institutionalized persons aged 60+ in Adelaide, South Australia. Aust Dent J (1993) 1.37

Pretreatment attrition and dropout in an outpatient clinic for anxiety disorders. Acta Psychiatr Scand (2004) 1.36

Promoting non-drug therapies. Aust N Z J Psychiatry (1993) 1.35

Procedural validity of the computerized version of the Composite International Diagnostic Interview (CIDI-Auto) in the anxiety disorders. Psychol Med (1995) 1.34

Drop-out rate as a performance indicator in psychotherapy. Acta Psychiatr Scand (1992) 1.33

Twelve-month prevalence and disability of DSM-IV bipolar disorder in an Australian general population survey. Psychol Med (2004) 1.31

Comparison of weight reduction with metoprolol in treatment of hypertension in young overweight patients. Lancet (1985) 1.30

Production and perception of "verbosity" in younger and older adults. Psychol Aging (1998) 1.30

Role of laminin in epithelium formation by F9 aggregates. J Cell Biol (1983) 1.30

Classification in psychiatry: ICD-10 versus DSM-IV. Br J Psychiatry (1999) 1.28

Being upset and becoming ill: an appraisal of the relation between life events and physical illness. Med J Aust (1978) 1.26

Genetic factors in stuttering confirmed. Arch Gen Psychiatry (1991) 1.25

Short- and long-term outcome in an intensive treatment program for adult stutterers. J Speech Hear Disord (1981) 1.25

How place matters: unpacking technology and power in health and social care. Health Soc Care Community (2005) 1.24

Social phobia in the Australian National Survey of Mental Health and Well-Being (NSMHWB). Psychol Med (2003) 1.23

Pediatric wandering spleen--the case for splenopexy: review of 35 reported cases in the literature. J Pediatr Surg (1989) 1.23

Stuttering: a review of research findings and theories circa 1982. J Speech Hear Disord (1983) 1.23

Asbestos disease in maintenance workers of the chemical industry. Ann N Y Acad Sci (1979) 1.13

Meta-analysis of the effects of stuttering treatment. J Speech Hear Disord (1980) 1.13

Stuttering: an investigation into cerebral dominance for speech. J Neurol Neurosurg Psychiatry (1972) 1.13

A systematic survey of 13 randomized trials of non-steroidal anti-inflammatory drugs for the prevention of heterotopic bone formation after major hip surgery. Acta Orthop Scand (2000) 1.13

UK consensus guidelines for the use of the protease inhibitors boceprevir and telaprevir in genotype 1 chronic hepatitis C infected patients. Aliment Pharmacol Ther (2012) 1.10

A scale to measure locus of control of behaviour. Br J Med Psychol (1984) 1.09

Twins: a test of the equal environments assumption. Acta Psychiatr Scand (1990) 1.07

Where should bipolar disorder appear in the meta-structure? Psychol Med (2009) 1.06

Controlled trial of exposure and response prevention in obsessive-compulsive disorder. Br J Psychiatry (1997) 1.06

The economic costs of schizophrenia. Implications for public policy. Arch Gen Psychiatry (1985) 1.05

Stereological estimates of nuclear number in human ventricular cardiomyocytes before and after birth obtained using physical disectors. J Anat (1997) 1.04

Psychological responses to illness and outcome after survived myocardial infarction: a long term follow-up. J Psychosom Res (1982) 1.03

Psychiatric illness in general practice. I: Why is it missed? Aust Fam Physician (1982) 1.02

alpha-Fetoprotein and albumin mRNA levels in liver regeneration and carcinogenesis. J Biol Chem (1983) 1.02

Validity of the Composite International Diagnostic Interview (CIDI) psychosis module in a psychiatric setting. J Psychiatr Res (1999) 1.02

Induction of relational schemas: common processes in reasoning and complex learning. Cogn Psychol (1998) 1.02

DSM-IV generalized anxiety disorder in the Australian National Survey of Mental Health and Well-Being. Psychol Med (2002) 1.01

Life event stress, social support, coping style, and risk of psychological impairment. J Nerv Ment Dis (1978) 1.00

Stuttering: considerations in the evaluation of treatment. Br J Disord Commun (1971) 0.99

Renal function impairment in secondary lead smelter workers: correlations with zinc protoporphyrin and blood lead levels. J Environ Pathol Toxicol (1980) 0.99

Neurological stuttering-a clinical entity? J Neurol Neurosurg Psychiatry (1977) 0.98

Alcohol and hypertension: implications for prevention and treatment. Ann Intern Med (1986) 0.98

Plasma lipoprotein levels in treated and untreated hypertensive men and women. The National Heart Foundation of Australia Risk Factor Prevalence Study. Arteriosclerosis (1985) 0.97

Behavior therapy and tricyclic medication in the treatment of obsessive-compulsive disorder: a quantitative review. J Consult Clin Psychol (1987) 0.97

Obesity, alcohol consumption and blood pressure in Australian men and women. The National Heart Foundation of Australia Risk Factor Prevalence Study. J Hypertens (1984) 0.97

Personality disorder in obsessive compulsive disorder: a controlled study. J Psychiatr Res (1996) 0.97

A comparison of ICD10 and DSM-IV criteria for posttraumatic stress disorder. J Trauma Stress (1999) 0.96

Oesophageal cancer and cachexia: the effect of short-term treatment with thalidomide on weight loss and lean body mass. Aliment Pharmacol Ther (2003) 0.96

Update of rubella immunisation in a school-based campaign. Med J Aust (1991) 0.96

Dysarthria of adult cerebral palsy: I. Intelligibility and articulatory impairment. J Speech Hear Res (1980) 0.96

Side effects of rubella immunisation in teenage girls. Med J Aust (1990) 0.96

An approach to the evaluation of stuttering therapy. J Speech Hear Res (1972) 0.95

Relationship of blood pressure to coronary and stroke morbidity and mortality in clinical trials and epidemiological studies. J Hypertens Suppl (1986) 0.94

Hospital infection with pneumococci resistant to tetracycline. Med J Aust (1967) 0.94

Cost-effectiveness of current and optimal treatment for adult asthma. Intern Med J (2006) 0.93

Internet cognitive behavioural therapy for mixed anxiety and depression: a randomized controlled trial and evidence of effectiveness in primary care. Psychol Med (2013) 0.93

Modelling the population cost-effectiveness of current and evidence-based optimal treatment for anxiety disorders. Psychol Med (2004) 0.93

Bayesian methods for meta-analysis of causal relationships estimated using genetic instrumental variables. Stat Med (2010) 0.93

A 25-year longitudinal, comparison study of the outcome of depression. Psychol Med (2001) 0.93

The Center for Epidemiological Studies Depression Scale in older community samples in Indonesia, North Korea, Myanmar, Sri Lanka, and Thailand. J Gerontol B Psychol Sci Soc Sci (1998) 0.92

Review article: 2014 UK consensus guidelines - hepatitis C management and direct-acting anti-viral therapy. Aliment Pharmacol Ther (2014) 0.92

The general practitioner's identification and management of emotional disorders. Aust Fam Physician (1977) 0.91

The Parental Bonding Instrument: a measure of perceived or actual parental behavior? Acta Psychiatr Scand (1991) 0.91

Potent activation of phosphatidylinositol 3'-kinase by simple phosphotyrosine peptides derived from insulin receptor substrate 1 containing two YMXM motifs for binding SH2 domains. Biochemistry (1994) 0.91

Stuttering: speech pattern characteristics under fluency-inducing conditions. J Speech Hear Res (1982) 0.91

DSM-IV and ICD-10 generalized anxiety disorder: discrepant diagnoses and associated disability. Soc Psychiatry Psychiatr Epidemiol (2001) 0.91

Antihypertensive treatment and plasma lipoprotein levels. The associations in data from a population study. Am J Med (1986) 0.91

A cusp catastrophe model analysis of changes in adolescent substance use: assessment of behavioural intention as a bifurcation variable. Nonlinear Dynamics Psychol Life Sci (2006) 0.91

Does non-clinical decompression stress lead to brain damage in abalone divers? Med J Aust (1986) 0.91

Neurocognitive disorders: cluster 1 of the proposed meta-structure for DSM-V and ICD-11. Psychol Med (2009) 0.90

Serum zinc, chromium, and iron concentrations in dogs with lymphoma and osteosarcoma. J Vet Intern Med (2001) 0.90

Psychiatric disorder in Canberra. A standardised study of prevalence. Acta Psychiatr Scand (1979) 0.89

Hydronephrosis and urine retention in estrogen-implanted athymic nude mice. Vet Pathol (2009) 0.89

The relation of social factors to physical and psychiatric illness. Am J Epidemiol (1978) 0.89

Tonic stretch reflexes in lip, tongue and jaw muscles. Brain Res (1979) 0.89

Stuttering: the results of 5 days treatment with an airflow technique. J Speech Hear Disord (1982) 0.88

Predicting abstainers in a smoking cessation programme administered by general practitioners. Int J Epidemiol (1988) 0.88

Comorbidity in the anxiety disorders: the use of a life-chart approach. J Psychiatr Res (1996) 0.88

Mouse hepatic metallothionein-I gene cleavage by micrococcal nuclease is enhanced after induction by cadmium. Nucleic Acids Res (1983) 0.88

Stratum-specific likelihood ratios of the general health questionnaire in the community: help-seeking and physical co-morbidity affect the test characteristics. Psychol Med (2002) 0.88